×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AVBP – arrivent biopharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AVBP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/25
08:31 am
avbp
ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts [Seeking Alpha]
Low
Report
ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts [Seeking Alpha]
12/22
06:01 pm
avbp
ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Low
Report
ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
12/22
08:55 am
avbp
ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer [Yahoo! Finance]
Low
Report
ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer [Yahoo! Finance]
12/22
08:00 am
avbp
ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer
Low
Report
ArriVent Announces First Patient Dosed in Global Pivotal Phase 3 ALPACCA Trial Evaluating Firmonertinib for First-Line Treatment of EGFR PACC Mutant Non-Small Cell Lung Cancer
12/16
01:17 pm
avbp
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
Low
Report
Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B
12/11
06:28 am
avbp
ArriVent BioPharma (NASDAQ:AVBP) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Low
Report
ArriVent BioPharma (NASDAQ:AVBP) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
12/10
07:21 am
avbp
ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
Low
Report
ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
12/9
08:10 am
avbp
ArriVent BioPharma (NASDAQ:AVBP) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
ArriVent BioPharma (NASDAQ:AVBP) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
04:53 pm
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: Octagon Capital Advisors LP
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: Octagon Capital Advisors LP
11/10
08:02 am
avbp
Form 10-Q ArriVent BioPharma, Inc. For: Sep 30
Low
Report
Form 10-Q ArriVent BioPharma, Inc. For: Sep 30
11/10
08:00 am
avbp
Form 8-K ArriVent BioPharma, Inc. For: Nov 10
Low
Report
Form 8-K ArriVent BioPharma, Inc. For: Nov 10
11/5
11:27 am
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: FMR LLC
10/30
02:04 pm
avbp
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: VANGUARD GROUP INC
10/17
06:06 pm
avbp
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: BlackRock, Inc.
10/15
04:07 pm
avbp
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: HBM Healthcare Investments (Cayman) Ltd.
Medium
Report
Form SCHEDULE 13G ArriVent BioPharma, Inc. Filed by: HBM Healthcare Investments (Cayman) Ltd.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: